Part 8/12:
Primarily, the kit aims to serve immunocompromised individuals, healthcare workers, and the elderly—groups with potentially weaker immune responses. The research team is working to commercialize the device, with plans to make it available in clinics and hospitals.
Expert Perspectives
Professor Peter Piser, involved in the innovation, explains that the science behind the test is similar to existing malaria tests but adapted to detect antibodies specific to COVID-19. While the current iteration requires professional operation and specialized equipment, future modifications might allow for at-home testing facilitated by mobile phone technology.